您的购物车当前为空
TA02 是一种Adezmapimod 类似物,是p38 MAPK 的抑制剂,其IC50值为 20 nM。它和Adezmapimod、SB 202190 具有相似的心源活性,可抑制 TGFBR-2。


为众多的药物研发团队赋能,
让新药发现更简单!
TA02 是一种Adezmapimod 类似物,是p38 MAPK 的抑制剂,其IC50值为 20 nM。它和Adezmapimod、SB 202190 具有相似的心源活性,可抑制 TGFBR-2。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 136 | In Stock | |
| 5 mg | ¥ 346 | In Stock | |
| 10 mg | ¥ 547 | In Stock | |
| 25 mg | ¥ 1,090 | In Stock | |
| 50 mg | ¥ 1,630 | In Stock | |
| 100 mg | ¥ 2,470 | In Stock | |
| 200 mg | ¥ 3,680 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 262 | In Stock |
TA-02 相关产品
| 产品描述 | TA-02 is a p38 MAPK inhibitor with IC50 of 20 nM.TA-02 especially inhibits TGFBR-2. |
| 靶点活性 | p38 MAPK:20 nM |
| 分子量 | 333.33 |
| 分子式 | C20H13F2N3 |
| CAS No. | 1784751-19-4 |
| Smiles | Fc1ccc(cc1)-c1nc([nH]c1-c1ccncc1)-c1ccccc1F |
| 密度 | 1.289 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (150 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (6 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容